Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer

INTRODUCTION: We performed a retrospective analysis of HER2-overexpressing metastatic breast cancer patients to describe clinical outcomes of those who, despite progression of the disease (PD), maintained trastuzumab for multiple chemotherapy lines. We also compared survival of these patients with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cancello, Giuseppe, Montagna, Emilia, D'Agostino, Diego, Giuliano, Mario, Giordano, Antonio, Di Lorenzo, Giuseppe, Plaitano, Monica, De Placido, Sabino, De Laurentiis, Michele
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575533/
https://www.ncbi.nlm.nih.gov/pubmed/18631394
http://dx.doi.org/10.1186/bcr2119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575533/
https://www.ncbi.nlm.nih.gov/pubmed/18631394
http://dx.doi.org/10.1186/bcr2119

Ejemplares similares